WHO vaccine-preventable diseases: monitoring system. 2013 global summary

Last updated 20-Octl-2013 (data as of 16-Oct-2013)
Next overall update June 2014
EPI mother and child logo         
Select a country

Development status: Developing GNI / capita (US$): 5'6701 Infant (under 12 months) mortality rate: 302
GDP / capita (US$): 7'4881 Child (under 5 years) mortality rate: 422

Population data in thousands3

  2012  2011  2010  2009  2008  2000  1990  1980 
Total population 2'259  2'218  2'179  2'143  2'111  1'898  1'415  1'013 
Births 60  59  59  59  59  59  54  43 
Surviving infants 58  57  57  57  57  56  50  40 
Pop. less than 5 years 283  281  280  279  278  276  234  188 
Pop. less than 15 years 826  823  821  817  814  768  618  472 
Female 15-49 years 609  594  580  567  554  481  338  221 

Number of reported case

(Click for retrospective incidence data for Namibia)
Diphtheria
Japanese encephalitis
Measles 86  79  3'138  4'076  469 
Mumps
Pertussis 16  15  30 
Polio*
Rubella 42  140  22  27 
Rubella (CRS)
Tetanus (neonatal) 10  11  10 
Tetanus (total) 10  13  11  148  19 
Yellow fever
* Polio refers to all polio cases (indigenous or imported), including polio cases caused by vaccine derived polio viruses (VDPV);"
"it does not include cases of vaccine-associated paralytic polio (VAPP) and cases of non polio acute flaccid paralysis [AFP]).

Percentage target population vaccinated by antigen

Hovering over an antigen reveals its fuller definition
  Most recent coverage survey4  

Official country estimates5

  (Click for retrospective coverage estimates data for Namibia)
Vaccine year result method % card seen                                                
BCG 2005  95  DHS   73.4  90  89  88  85  88  77  88 
DTP1 2005  95  DHS   73.4  89  88  87  87  88  90 
DTP3 2005  83  DHS   73.4  84  82  83  83  83  79  59 
HepB_BD         
HepB3          84  82  83 
Hib3          84  82  83 
JapEnc         
MCV 2005  84  DHS   73.4  76  74  75  76  73  69  57 
MCV2         
PCV1         
PCV3         
Pol3 2005  79  DHS   73.4  84  85  83  83  83  80  59 
Rota1         
Rota_last         
Rubella1         
TT2plus 1991  33  DHS   70.2  67  64  75  69  71  60  50 
PAB         
VAD1          75  74  64  93  62 
YFV         
  ° indicates that more than 1 survey occurred that year

  Next update: July 2014

WHO-UNICEF estimates6

  (Click for full retrospective WHO-UNICEF coverage estimates data for Namibia)
BCG 90  89  88  85  88  77 
DTP1 89  88  87  87  88  90 
DTP3 84  82  83  83  83  79 
HepB3 84  82  83 
Hib3 84  82  83 
MCV 76  74  75  76  73  69 
PAB 83  83  83  82  82  74 
PCV3
Pol3 84  85  83  83  83  80 
Rota_last

Number of districts in the country 34  Proportion of
districts reporting
DTP3 coverage:
% of coverage reports received at national
level vs number of reports expected
 
   
/
|
|
\
Greater or equal to 90% 29
From 80 to 89% 38
From 50 to 79% 32
Less than 50% 0
Proportion of districts
not reporting DTP3 coverage
0
 

Immunization Schedule (2012 or latest available)

Hovering over an antigen reveals its fuller definition
Vaccine Schedule Entire country Comment
BCG birth; Yes
DT 5, 10 years; Yes
DTwPHibHep 6, 10, 14 weeks; Yes
Measles 9 months; Yes
OPV Birth; 6, 10, 14 weeks; 5, 10 years; Yes
Pneumo_conj Yes From September 2013
Rotavirus Yes From September 2013
VitaminA 9 months; Yes

Immunizaton indicators

Indicator Expected answer 2012  2011  2010  2009  2008  2007  2006 

Planning and management

Multi-year plan (MYP) for immunization Yes/No/NR Yes  Yes  Yes  No  Yes  No  Yes 
What years does the MYP cover? number 2011 - 2015  2011 - 2015  2011 - 2015    2006-2010    2006-2010 
Nº of districts with microplans that include activities to raise immunization coverage number         34  34  34 

National Immunization Advisory Mechanism

Does the country have a standing technical advisory group on immunization? Yes/No/NR No  No  No         

System performance

Total number of districts in country number 34  34  34  34  34  34  34 
Nº districts with DTP3 coverage >=80% number 23  23  23  22  22  11 
% of districts with DTP3 coverage >=80% From 0 to 100% 68  68  68  65  65  15  32 
Nº districts with measles (MCV1) coverage >=95% number    
% of districts with MCV1 coverage >=95% From 0 to 100% 12  15  18     

Safety

Monitoring of Adverse Events Following Immunization (AEFI)? Yes/No/NR Yes  No    Yes  Yes  Yes  Yes 
Does your country have a vaccine adverse events review committee? Yes/No/NR/ND Yes  Yes           

Finance

Percentage of routine vaccines funded by Government From 0 to 100% 45  100  100  100  100  100  100 

Maternal and neonatal tetanus (NT) elimination

NT eliminated Yes/No Yes  Yes  Yes  Yes  Yes  Yes  Yes 

Sources

Unless otherwise specified, data provided by Member States through WHO-UNICEF Joint Reporting Form and WHO Regional offices.
 1  "The 2013 World Bank Development Indicators Online", GDP per capita is PPP adjusted.
 2  World Health Statistics 2012, data for 2011
 3  "United Nations, Population Division. The World Population Prospects - the 2012 revision". New York, 2013.
 4  UNICEF/WHO survey database
 5  If no official estimate is available, the administrative coverage is reported. '*' indicates coverage over 99.5%.
 6  WHO-UNICEF estimates.